Starting as a botanical extraction and plant-based ingredient manufacturer, Radient Technologies is now developing cannabis products and formulations unlike any other on the market.
Radient Technologies has come a long way over the last two years. Founded in 2001 by Dr Steven Splinter, the company began as a botanical extraction and plant-based ingredient manufacturer. But as the legal cannabis industry began to take hold around the world, Radient soon discovered its highly efficient proprietary extraction technology was a perfect fit.
The rise of Radient
After Canada began the process of legalising cannabis in 2016, Radient found itself at the centre of a booming brand new industry that was growing at breakneck speed. Suddenly, Radient was fielding requests from cannabis companies looking for an extraction solution which could meet the industry’s increasingly specific demands.
Radient’s proprietary extraction technology is unique for several reasons. First, it is based on a continuous-flow method which allows for much higher volumes of cannabis biomass to be processed in much less time than existing extraction methods.
Radient can scale up production to industrial scale volumes easily without the need to purchase an endless supply of new machinery, thanks to a proprietary, continuous-flow platform that does not rely on pressurised batch vessels. This means higher rates of consistency and quality are achieved because Radient’s process doesn’t require stopping and restarting material flows. As a result, additional machine time and human labour are generally not needed when scaling up to larger volumes.
In addition, this unique continuous-flow extraction method allows Radient to recover more cannabinoids from cannabis biomass (up to 99%), giving the company access to a wider range of the natural active compounds found in the cannabis plant.
Further, because of this rapid speed extraction technology, there is less cannabinoid degradation that happens during processing, allowing the company to develop higher quality cannabis extracts and formulations with greater product stability.
Meeting European market demand
With the legalisation of medical cannabis spreading to more countries throughout Europe, Radient has chosen to set up its first non-Canadian extraction and product development facility in Germany.
When complete this facility will process more than 280,000 kg of cannabis per year, and more than 2.8 million kg of hemp per year. The company has also set up an additional R&D laboratory facility near Lyon, France for additional analysis and formulation development.
With the commencement of its operations in Germany, Radient will further complement its existing Canadian facilities. Currently, Radient’s Canadian cannabis extraction and product development facility based in Edmonton, Alberta has a throughput capacity of more than 56,000 kg/year of cannabis, with an additional extraction throughput capacity of 420,000 kg/year of hemp coming online in early 2020. The facilities are based near the company’s full-scale 18,000 sq ft research & development laboratory, where Radient’s team of in-house scientists are working on groundbreaking new ingredients and formulations.
An additional throughput capacity of 280,000kg per year of cannabis and 2.8 million kg per year of hemp will also be coming online at Radient’s Alberta facilities by the end of 2020. This will give Radient a total throughput capacity of more than 600,000kg per year of cannabis; and more than six million kg per year of hemp across Canada and Germany.
Want to learn more about the world of Radient Technologies? Click here for further information: https://www.radientinc.com/about
PLEASE NOTE: WE DO NOT SUPPLY RAW CANNABIS MATERIALS.